Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 16 studies | 35% ± 14% | |
plasmablast | 5 studies | 49% ± 21% | |
B cell | 4 studies | 34% ± 4% |
Insufficient scRNA-seq data for expression of MYBL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 801.99 | 328 / 328 | 61% | 38.22 | 109 / 178 |
skin | 71% | 792.59 | 1286 / 1809 | 89% | 70.81 | 418 / 472 |
intestine | 51% | 445.05 | 490 / 966 | 95% | 137.98 | 501 / 527 |
lung | 60% | 230.24 | 349 / 578 | 83% | 96.96 | 962 / 1155 |
stomach | 46% | 323.95 | 164 / 359 | 94% | 141.17 | 269 / 286 |
esophagus | 41% | 430.05 | 587 / 1445 | 98% | 147.89 | 180 / 183 |
bladder | 24% | 37.71 | 5 / 21 | 89% | 131.06 | 451 / 504 |
uterus | 5% | 17.51 | 8 / 170 | 97% | 168.96 | 445 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 434.42 | 29 / 29 |
spleen | 100% | 3501.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 198.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.86 | 1 / 1 |
ovary | 7% | 37.01 | 12 / 180 | 93% | 112.52 | 398 / 430 |
breast | 19% | 49.48 | 89 / 459 | 73% | 75.85 | 821 / 1118 |
peripheral blood | 89% | 3340.41 | 826 / 929 | 0% | 0 | 0 / 0 |
liver | 19% | 71.97 | 42 / 226 | 38% | 23.20 | 154 / 406 |
adrenal gland | 23% | 46.00 | 59 / 258 | 10% | 4.77 | 23 / 230 |
brain | 1% | 1.33 | 15 / 2642 | 32% | 25.46 | 223 / 705 |
kidney | 17% | 81.10 | 15 / 89 | 7% | 3.70 | 67 / 901 |
prostate | 15% | 40.33 | 36 / 245 | 10% | 4.52 | 48 / 502 |
thymus | 10% | 50.74 | 65 / 653 | 14% | 19.93 | 86 / 605 |
adipose | 23% | 61.63 | 271 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 8% | 17.90 | 104 / 1335 | 0% | 0 | 0 / 0 |
heart | 4% | 11.99 | 37 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.64 | 2 / 80 |
muscle | 0% | 0.36 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005829 | Cellular component | cytosol |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031523 | Cellular component | Myb complex |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | MYBL2 |
Protein name | Myb-related protein B (B-Myb) (Myb-like protein 2) |
Synonyms | BMYB |
Description | FUNCTION: Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene. . |
Accessions | P10244 ENST00000217026.5 [P10244-1] ENST00000396863.8 [P10244-2] |